US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 6.320
  • -0.360-5.39%
Close Oct 31 16:00 ET
  • 6.350
  • +0.030+0.47%
Post 16:16 ET
1.84BMarket Cap-3807P/E (TTM)

Recursion Pharmaceuticals Key Stats

Recursion Pharmaceuticals Q3 2024 Estimates Date

Currency:USDNov 6, 2024

Estimate YoY
Revenue
29.83M
+183.19%
EPS
-0.35
+18.49%
Buy

Oct 31, 2024

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 14.600M--
Nov 6, 20242024/Q3-- / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 14.600M--
Nov 6, 20242024/Q3-- / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--

Unlock Free Earnings Estimates

Recursion Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Oct 31, 2024

Buy

  • Buy

    28.57%
  • Hold

    71.43%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data